Published Date: 23 Apr 2023
According to the study, prolonged exposure to nitrogen dioxide, particulate matter PM2.5, and nitrogen oxide may raise the risk of dementia.
Read Full NewsNeurologists Michael Levy, MD, PhD, and Fu-Dong Shi, MD, PhD, discuss the rationale, design, and clinical implications of the phase 3 DAWN trial evaluating daratumumab in aquaporin-4–positive NMOSD.
Ava L. Liberman, MD, assistant professor of clinical neurology at Weill Cornell Medicine, shared key takeaways from stroke data presented at the 2026 International Stroke Conference.
ACP urged to drop “provider” for physicians, warning it blurs expertise, commodifies care, and erodes professional identity, trust, and the patient relationship.
Phase 3 DAWN data show daratumumab cuts NMOSD relapse risk 76%, stays well tolerated, and may improve disability, signaling a new targeted option.
Siegel addressed additional points presented in his Maui Derm 2026 session, 'How To Maximize Your Billing Effectiveness in the Era of Dwindling Reimbursements and ICD-10.'
7 Pulmonology Headlines You Missed in January 2026
1.
Integrative palliative care is critical to improving mental health among pancreatic cancer patients
2.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
3.
Experts Debate AQUILA Trial Findings in Smoldering Multiple Myeloma
4.
Dietary Intervention Shows Promise in Blood Cancers
5.
New BCMA-Directed Therapies Show Promise in Multiple Myeloma
1.
Unlocking the Mystery of Granulomas: A Closer Look at the Causes and Treatment
2.
Epigenetics and Resistance: Mechanisms in Histone Methylation-Targeted Therapies
3.
Genetic Screening: A Game Changer in Cancer Prevention
4.
All You Need to Know About Mesna: The Ultimate Guide
5.
Everything You Need to Know About the Latest Hyponatremia Algorithm
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
3.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation